FDA Adverse Event Injury Summary report: N

CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED

MDR report key: 12443406 · Received September 8, 2021

Report

Report Number
2025587-2021-02764
Event Type
Injury
Date Received
September 8, 2021
Date of Event
May 15, 2019
Report Date
September 8, 2021
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
MWH
PMA / PMN Number
H020003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: LUECK S ET AL. HYDROXYLAPATITE DEPOSITION INDUCES GRAFT ALTERATIONS IN CHD PATIENTS. CARDIOLOGY IN THE YOUNG. 2019; 29(SUPP. 1):S84. DOI: 10.1017/S1047951119000489, EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A RETROSPECTIVE ANALYSIS INTO THE CALCIFICATION-DEPENDENT ALTERATIONS OF VARIOUS TYPES OF GRAFTS IN PATIENTS WITH CONGENITAL HEART DISEASE. ALL DATA WERE COLLECTED FROM A SINGLE CENTER. THE STUDY POPULATION INCLUDED 7 PATIENTS, 3 OF WHOM WERE IMPLANTED WITH MEDTRONIC CONTEGRA PULMONARY VALVED CONDUIT (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). AMONG ALL MEDTRONIC CONTEGRA PATIENTS, ADVERSE EVENTS INCLUDED: CONDUIT EXPLANTATION DUE TO CALCIUM-BASED DEPOSITS (CALCIUM PHOSPHATES AND HYDROXYLAPATITE). BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS DIRECTLY ASSOCIATED WITH THE ADVERSE EVENTS. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1340390 CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED PULMONIC VALVED CONDUIT MWH MEDTRONIC HEART VALVES DIVISION 200S

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R